The Female Health Company today announced that its exclusive distributor in the Republic of South Africa (RSA), Sekunjalo Investments Corporation (PTY) Ltd., was awarded a contract to supply the Ministry of Health (MOH) up to 11 million FC2 Female Condoms. The contract is valid through August 31, 2012. The tender quantity of 11 million units is a significant increase from the RSA’s last tender (4 million units), evidencing the country’s growing demand for female condoms. Units supplied during the contract term can be increased over the specified quantity at the purchasers’ request.
O.B. Parrish, Chairman and C.E.O. of The Female Health Company, noted that “the Company is delighted at RSA’s decision to continue to supply our high-quality, effective product that provides women with options to control their sexual health, particularly HIV/AIDS prevention”.
The FC2 Female Condom has been approved by the FDA as a Class III medical device and has been cleared by the World Health Organization for purchase by U. N. Agencies.
